참고문헌 (20)

1. Popescu BF, Lucchinetti CF. Pathology of demyelinating diseases. Annual Review of Pathology: Mechanisms of Disease. 2012;7:185-217. 

   상세보기

2. Berger T, Rubner P, Schautzer F, Egg R, Ulmer H, Mayringer I, Dilitz E, Deisenhammer F, Reindl M. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. New England Journal of Medicine. 2003;349(2):139-45. 

   상세보기

3. Ambrosius W, Michalak S, Kozubski W, Kalinowska A. Myelin oligodendrocyte glycoprotein antibodyassociated disease: current insights into the disease pathophysiology, diagnosis and management. International Journal of Molecular Sciences. 2020;22(1):100. 

4. De Mol CL, Wong Y, van Pelt ED, Wokke BHA, Siepman TAM, Neuteboom RF, Hamann D, Hintzen RQ. The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults. Multiple Sclerosis Journal. 2020;26:806-14. 

5. Reindl M, Waters P. Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nature Reviews Neurology. 2019;15(2):89-102. 

   상세보기

6. Kezuka T, Ishikawa H. Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis. Japanese Journal of Ophthalmology. 2018;62(2):101-8. 

   상세보기

7. KIM YH. Mechanism of neurolasticity after brain injury and neurorehabilitation. Brain & NeuroRehabilitation. 2008;1(1);6-11. 

   상세보기

8. Lee C, Cho IH, Heo GY, Kang HK, Kim MH, Han CW, Kim SY, Choi JY, Park SH, Yun YJ, Hong JW, Kwon JN, Park EY, Lee I. Analysis of the numeric rating scale (NRS) used in clinical studies based on randomized controlled studies. The Journal of Internal Korean Medicine. 2021;42(4):510-31. 

9. Thompson AJ, Turner AJ. A comparison of the EQ-5D3L and EQ-5D-5L. Pharmacoeconomics. 2020;38:575-91. 

   상세보기

10. Fairbank JC, Pynsent PB. The Oswestry disability index. Spine. 2000;25(22):2940-52. 

11. Ohura T, Hase K, Nakajima Y, Nakayama T. Validity and reliability of a performance evaluation tool based on the modified Barthel Index for stroke patients. BMC Medical Research Methodology. 2017;17(1):1-8. 

12. Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hummert MW, Ringelstein M, Trebst C, Winkelmann A, Schwarz A, Buttmann M, Zimmermann H, Kuchling J, Franciotta D, Capobianco M, Siebert E, Lukas C, Korporal-Kuhnke M, Haas J, Fechner K, Brandt AU, Schanda K, Aktas O, Paul F, Reindl M, Wildemann B. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. Journal of Neuroinflammation. 2016;13:280. 

    상세보기

13. Spadaro M, Gerdes LA, Krumbholz M, Ertl-Wagner B, Thaler FS, Schuh E, Metz I, Blaschek A, Dick A, Bruck W, Hohlfeld R, Meinl E, Kumpfel T. Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis. Neurology Neuroimmunology & Neuroinflammation. 2016;3(5):e257. 

    상세보기

14. Ramanathan S, Mohammad S, Tantsis E, Nguyen TK, Merheb V, Fung VSC, White OB, Broadley S, Lechner-Scott J, Vucic S, Henderson APD, Barnett MH, Reddel SW, Brilot F, Dale RC. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. Journal of Neurology, Neurosurgery and Psychiatry. 2018;89(2):127-37. 

    상세보기

15. Criado MB, Santos MJ, Machado J, Goncalves AM, Greten HJ. Effects of Acupuncture on gait of patients with multiple sclerosis. The Journal of Alternative and Complementary Medicine. 2017;23(11):852-7. 

    상세보기

16. Hadi S, Khadijeh O, Hadian M, Niloofar AY, Olyaei G, Hossein B, Calv o S, Herrero P. The effect of dry needling on spasticity, gait and muscle architecture in patients with chronic stroke: a case series study. Topics in Stroke Rehabilitation. 2018;25(5):326-32. 

    상세보기

17. Lee JH, Shin JS, Lee YJ, Kim MR, Ahn YJ, Park KB, Kropf MA, Shin BC, Lee MS, Ha IH. Effects of Shinbaro pharmacopuncture in sciatic pain patients with lumbar disc herniation: study protocol for a randomized controlled trial. Trials. 2015;16:1-11. 

18. Kim Y, Shin JS, Kim DW. The clinical effect of Cheongpa-jeon on the group of patients who were treated under conservative remedies for LBP (Low Back Pain). The Journal of Korea CHUNA Manual Medicine. 2004;5(1):85-92. 

19. Park SY, Kim KS. The overview of Orientalmedicine about herniated lumbar interbertebral disc - focusing on Donguibogam. The Journal of Korean Oriental Medical Society. 1995;16(1):160-71. 

20. Shin JS, Ha IH, Lee JH, Choi YK, Kim MR, Park BY, Shin BC. Effects of motion style acupuncture treatment in acute low back pain patients with severe disability: a multicenter, randomized, controlled, comparative effectiveness trial. Pain. 2013;154(7):1030-7. 

    상세보기